Reading Published Dose Ranges Correctly Retatrutides Phase 3 TRIUMPH-1 trial, with topline results reported by Eli Lilly in May 2026, evaluated three target doses 4mg, 9mg, and 12mg weekly with all arms starting at 2mg and escalating in steps every four weeks (2mg 4mg 6mg 9mg 12mg, depending on target arm) rather than starting at the target dose directly
14 Low B12 and/or low folate are both risk factors for high homocysteine, which is common in people with MTHFR mutations
Our clients who rate their hangovers a 10/10 typically report improvement to a 3/10 or better after this treatment
Rare but Serious Reactions: Seek immediate medical attention for signs of a severe allergic reaction (anaphylaxis), such as hives, difficulty breathing, or swelling of the face and throat
The 2024 NICE guideline stresses tailoring the schedule to your symptoms and reviewing it, rather than treating one figure as fixed